Diagnostic Technologies for Infectious and Parasitic Diseases


Meridian Bioscience Europe companies are subsidiaries of Meridian Bioscience, Inc. a fully integrated life sciences company that manufactures, markets and distributes a broad range of innovative diagnostic test kits in more than 60 countries around the world.
Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, urinary and respiratory infections.
Meridian has a strong market position in the area of gastrointestinal infections, particularly with its patented Helicobacter pylori Stool Antigen test (HpSA), the first totally non-invasive test for diagnosing H.pylori infection.
The Company's shares are traded through Nasdaq's National Market, symbol VIVO. For more financial information and investments opportunities, visit the corporate website.

The Meridian Bioscience Europe subsidiaries are selling directly the product range in Belgium, France, Italy, Luxembourg and The Netherlands, and through exclusive distributors in most other countries in Europe, Middle East and Africa.

The Meridian Life Science, Inc. subsidiary (meridianlifescience.com) is recognized as an industry leader in the supply of monoclonal and polyclonal antibodies, purified antigens, assay development reagents and custom antibody services to Pharmaceutical / Biotech / Diagnostic companies, as well as Academic researchers. Its cGMP biopharmaceutical production laboratories can develop and produce purified recombinant therapeutic proteins, monoclonal antibodies and other cell culture proteins for human-phase drug trials or small commercial scale requirements.